Comments
Loading...

Cannapharmarx Analyst Ratings

CPMDOTCPK
Logo brought to you by Benzinga Data
$0.0126
0.00713129.65%
Pre-Market: Mar 15, 4:00 PM EDT

Cannapharmarx Analyst Ratings and Price Targets | OTC:CPMD | Benzinga

Cannapharmarx Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Cannapharmarx Corp from these most-recent analyst ratings.

Analyst Ratings for Cannapharmarx

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Cannapharmarx (CPMD) stock?

A

There is no price target for Cannapharmarx

Q

What is the most recent analyst rating for Cannapharmarx (CPMD)?

A

There is no analyst for Cannapharmarx

Q

When was the last upgrade for Cannapharmarx (CPMD)?

A

There is no last upgrade for Cannapharmarx

Q

When was the last downgrade for Cannapharmarx (CPMD)?

A

There is no last downgrade for Cannapharmarx.

Q

When is the next analyst rating going to be posted or updated for Cannapharmarx (CPMD)?

A

There is no next analyst rating for Cannapharmarx.

Q

Is the Analyst Rating Cannapharmarx (CPMD) correct?

A

There is no next analyst rating for Cannapharmarx.

Browse analyst ratings and price targets on all stocks.